Patrick Loehrer, MD
Enriched profileHH Gregg Professor of Oncology and Distinguished Professor of Indiana University; Director of Indiana University Melvin and Bren Simon Cancer Center; Associate Dean for Cancer Research · Indiana University School of Medicine
Patrick Loehrer is HH Gregg Professor of Oncology and Distinguished Professor of Indiana University; Director of Indiana University Melvin and Bren Simon Cancer Center; Associate Dean for Cancer Research at Indiana University School of Medicine. OpenAlex indexes 535 publications with 26,146 citations (h-index 80); ClinicalTrials.gov lists 11 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 10% of Hematology / Oncology profiles in the findmyKOL directory.
Data verified 14 Oct 2026
Overview
Updated 14 Oct 2026
Patrick Loehrer, MD, is HH Gregg Professor of Oncology and Distinguished Professor of Indiana University at Indiana University School of Medicine. The public record shows 535 publications with 26,146 citations (h-index 80), centered on Testicular diseases and treatments, Myasthenia Gravis and Thymoma, Cardiac tumors and thrombi. It also documents an investigator role on 11 registered clinical trials, industry payments reported by 1 companies, 5 NIH-funded awards (1985–2024).
- Most recent indexed publication: 2026 · JCO global oncology
- Top research focus: Testicular diseases and treatments
- 11 registered trials on ClinicalTrials.gov
- Open Payments reporting from 1 companies
Generated from the cited public record · current as of 14 Oct 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 13 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 241.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 14 Oct 2026
Listed as an investigator on 11 registered studies on ClinicalTrials.gov. The most recent:
- Study of Lonsurf in Combination With Gemcitabine and Nab-Paclitaxel in Patients With Advanced (PDAC)
Sponsor: Patrick Joseph Loehrer Sr.
- A Study of BKM120 (Buparlisib) in Relapsed or Refractory Thymomas
Sponsor: Patrick Joseph Loehrer Sr.
Industry payments
Updated 14 Oct 2026
1 company reported payments to CMS in program years 2021–2021. These are public disclosures, not judgments. The latest:
- Novartis Pharmaceuticals CorporationProgram year20211 payment
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
40.8%Atypical Antipsychotic19.4%Olanzapine100%Part D<11 patientsOpioid Agonist10.7%Oxycodone Hcl100%Part D<11 patients+ 1 more class in this area
Sensory organs
23.3%Corticosteroid23.3%Dexamethasone100%Part D<11 patientsMetabolism & gastrointestinal
21.4%Antidiarrheal microorganisms21.4%Creon100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 14 Oct 2026
5 NIH research awards on record, funded 1985–2024 per NIH RePORTER. The latest:
- The East Africa Consortium for HPV and Cervical Cancer in Women living with HIV/AIDS
Indiana University Indianapolis
FY2024$926,411U54CA254518 - The East Africa Consortium for HPV and Cervical Cancer in Women living with HIV/AIDS
Indiana University Indianapolis
FY2023$923,799U54CA254518
Congress activity
Updated 14 Oct 2026
57 congress contributions (1986–2026) across AACR, ASCO, ESMO per OpenAlex. The most recent:
- Abstract 6587: Characterizing the autoreactome in thymoma-associated myasthenia gravis
AACR Annual Meeting
AACR2026Co-author - A multi-level qualitative exploration of factors influencing breast and cervical cancer screening uptake in Nepal.
ASCO Annual Meeting
ASCO2025Co-author - Leveraging AI predictive models to develop thymic tumor–specific peptides mimicking COL17A1 alterations.
ASCO Annual Meeting
ASCO2025Co-author
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 14 Oct 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Integrated Molecular and Clinical Analysis of Thymic Epithelial Tumors.
JCO precision oncology
Article2026 - Oncologic outcomes and predictors of recurrence following minimally invasive and open surgery for thymoma.
Journal of thoracic disease
Article2025
Most-cited works
by citation count (OpenAlex)- 01
- 02
- 03
- 04CisplatinArticle947 citations1984
- 05Bilateral Orchiectomy with or without Flutamide for Metastatic Prostate CancerArticle861 citations1998
Network
Updated 14 Oct 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Background & recognition
Updated 14 Oct 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →fsph.iupui.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →fsph.iupui.edu ↗
Editorial & leadership roles
journal and society appointments- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →honorsandawards.iu.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →en.wikipedia.org ↗
- Editor-in-Chief
Yearbook of Oncology
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →honorsandawards.iu.edu ↗ - Board Member
American Society of Clinical Oncology
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →fsph.iupui.edu ↗ - Chair
Medical Oncology Subcommittee, American Board of Internal Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →fsph.iupui.edu ↗ - Director
Division of Hematology/Oncology, Indiana University School of Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →en.wikipedia.org ↗
Awards & honors
honors on the public record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →honorsandawards.iu.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →en.wikipedia.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →en.wikipedia.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →honorsandawards.iu.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →honorsandawards.iu.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →honorsandawards.iu.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →honorsandawards.iu.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →en.wikipedia.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →en.wikipedia.org ↗
- Exceptional Service Award
Foundation for Thymic Research
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →fsph.iupui.edu ↗
Secondary affiliations
appointments beyond the home institution- Founding Director
AMPATH-Oncology Program
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →fsph.iupui.edu ↗ - Advisory Committee Member
Indiana University Center for Global Health
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →fsph.iupui.edu ↗
Media & interviews
press, podcasts and appearances- Podcast host
Oncology, Etc. (American Society of Clinical Oncology)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →en.wikipedia.org ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Douglas Zipes, MD
Indiana University School of Medicine
Linda Dimeglio, MD
Indiana University School of Medicine
Robert Tepper, MD
Indiana University School of Medicine
Viral Shah, MD
Indiana University School of Medicine
Howard Scher, MD
Memorial Sloan Kettering Cancer Center
Toni Choueiri, MD
Dana-Farber Cancer Institute
Robert Motzer, MD
Memorial Sloan Kettering Cancer Center
Fred Saad, MD
Centre hospitalier de l'Université de Montréal (CHUM)